The FDA's approval of Alhemo (concizumab-mtci) revolutionizes hemophilia treatment, offering a simpler, subcutaneous injection for better bleed control and patient independence.

Medical experts share the main symptoms of Hemophilia A+B, a blood-clotting disorder. From excessive bleeding to bruising, here’s what to look out for.

A 26-year-old Downriver man seen at Children’s Hospital of Michigan in Detroit since infancy for a rare bleeding disorder in ...

Medical experts share the main symptoms of Hemophilia A+B, a blood-clotting disorder. From excessive bleeding to bruising, here’s what to look out for.

(MENAFN- GlobeNewsWire - Nasdaq) The Global Coagulation Factor Deficiency Market Report (2025-2035) highlights advances in treatment options for blood clotting disorders like Hemophilia A ...

Free blood test services are now available at the Peñarrubia Rural Health Unit (RHU) with a new hematology machine.

The Global Coagulation Factor Deficiency Market Report (2025-2035) highlights advances in treatment options for blood clotting disorders like Hemophilia A, Hemophilia B, and Von Willebrand Disease.

Jigar Kotecha, Secretary of the Hemophilia Society (Mumbai Chapter), said that a purchase order for 6,130 vials was issued on ...

TEHRAN – The national week to support individuals with hemophilia will be held from July 23 to 29. Hemophilia is usually an inherited bleeding disorder in which the blood does not clot properly, and ...

The Hemophilia Society, Mumbai Chapter, has raised serious concerns over the non-availability of Anti-Hemophilic Factor (AHF) — a critical protein required for blood clotting in hemophilia patients.